Dissecting the pathways that destabilize mutant p53: The proteasome or autophagy?

Cell Cycle

Volumn 12, Issue 7, 2013, Pages 1022-1029

  Choudhury, Sujata ^a   Kolukula, Vamsi K ^a   Preet, Anju ^a   Albanese, Chris ^a   Avantaggiati, Maria Laura ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Autophagy; Cancer; Mutant; Mutations; P53; Proteasome; Ubiquitin tumor

Indexed keywords

AUTOPHAGY PROTEIN 5; BECLIN 1; PROTEASOME; PROTEIN P53;

AUTOPHAGY; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; UBIQUITINATION;

EID: 84875906475     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24128     Document Type: Review

References (50)

1. Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev 2012; 26:1268- 86; PMID:22713868; http://dx.doi.org/10.1101/gad.190678.112
2. Donehower LA, Lozano G. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer 2009; 9:831-41; PMID:19776746; http://dx.doi.org/10.1038/nrc2731
3. Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9:701-13; PMID:19693097
4. Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, et al. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 2008; 22:1337-44; PMID:18483220; http://dx.doi.org/10.1101/gad.1662908
5. Puca R, Nardinocchi L, Porru M, Simon AJ, Rechavi G, Leonetti C, et al. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs. Cell Cycle 2011; 10:1679-89; PMID:21508668; http://dx.doi. org/10.4161/cc.10.10.15642
6. Napoli M, Girardini JE, Piazza S, Del Sal G. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Oncotarget 2011; 2:654-6; PMID:21926448
7. Quante T, Otto B, Brázdová M, Kejnovská I, Deppert W, Tolstonog GV. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Cell Cycle 2012; 11:3290-303; PMID:22894900; http://dx.doi.org/10.4161/cc.21646
8. Valenti F, Fausti F, Biagioni F, Shay T, Fontemaggi G, Domany E, et al. Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop. Cell Cycle 2011; 10:4330- 40; PMID:22134238; http://dx.doi.org/10.4161/cc.10.24.18682
9. Haupt S, Haupt Y. Mutant p53 subverts PLK2 function in a novel, reinforced loop of corruption. Cell Cycle 2012; 11:217-8; PMID:22214663; http://dx.doi.org/10.4161/cc.11.2.18977
10. Yang Y, Tarapore RS, Jarmel MH, Tetreault MP, Katz JP. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle 2012; 11:4033-9; PMID:22990386; http://dx.doi.org/10. 4161/cc.22265
11. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847-60; PMID:15607980; http://dx.doi. org/10.1016/j.cell.2004.11.004
12. Ebina M, Martínez A, Birrer MJ, Ilona Linnoila R. In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers. Oncogene 2001; 20:2579-86; PMID:11420668; http://dx.doi.org/10. 1038/sj.onc.1204351
13. Ebina M, Steinberg SM, Mulshine JL, Linnoila RI. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994; 54:2496-503; PMID:7909277
14. Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol 2011; 223:116- 26; PMID:21125670; http://dx.doi.org/10.1002/path.2784
15. Ding WX, Yin XM. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008; 4:141-50; PMID:17986870
16. Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, et al. Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle 2012; 11:4436-46; PMID:23151455; http://dx.doi. org/10.4161/cc.22778
17. Moon SH, Prives C. Mutant p53 succumbs to starvation. Cell Cycle 2013; 12; PMID:23421997
18. Lagory EL, Giaccia AJ. A low-carb diet kills tumor cells with a mutant p53 tumor suppressor gene: The Atkins diet suppresses tumor growth. Cell Cycle 2013; 12; PMID:23422857; http://dx.doi. org/10.4161/cc.23948
19. Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011; 147:223-34; PMID:21962518; http://dx.doi. org/10.1016/j.cell.2011.08. 037
20. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42; PMID:18191218; http://dx.doi.org/10.1016/j.cell.2007.12.018
21. Liu EY, Ryan KM. Autophagy and cancer-issues we need to digest. J Cell Sci 2012; 125:2349- 58; PMID:22641689; http://dx.doi.org/10.1242/jcs.093708
22. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447:859- 63; PMID:17568747; http://dx.doi.org/10. 1038/nature05853
23. Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T, et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol 2010; 12:781-90; PMID:20639871; http://dx.doi. org/10.1038/ncb2082
24. Qing G, Yan P, Qu Z, Liu H, Xiao G. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res 2007; 17:520-30; PMID:17563756; http://dx.doi. org/10.1038/cr.2007.47
25. Yan P, Qing G, Qu Z, Wu CC, Rabson A, Xiao G. Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: implications for therapeutic interventions. Autophagy 2007; 3:600-3; PMID:17671417
26. Goussetis DJ, Gounaris E, Wu EJ, Vakana E, Sharma B, Bogyo M, et al. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood 2012; 120:3555-62; PMID:22898604; http://dx.doi. org/10.1182/blood-2012-01-402578
27. Isakson P, Bjørås M, Bøe SO, Simonsen A. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood 2010; 116:2324-31; PMID:20574048; http://dx.doi.org/10.1182/blood- 2010-01-261040
28. Sandilands E, Serrels B, Wilkinson S, Frame MC. Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells. EMBO Rep 2012; 13:733-40; PMID:22732841; http://dx.doi. org/10.1038/embor.2012.92
29. Hsueh YS, Yen CC, Shih NY, Chiang NJ, Li CF, Chen LT. Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors. Autophagy 2013; 9:220- 33; PMID:23196876; http://dx.doi.org/10.4161/auto.22802
30. Sariyer IK, Merabova N, Patel PK, Knezevic T, Rosati A, Turco MC, et al. Bag3-induced autophagy is associated with degradation of JCV oncoprotein, T-Ag. PLoS ONE 2012; 7:e45000; PMID:22984599; http://dx.doi.org/10.1371/journal.pone. 0045000
31. Lamark T, Johansen T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int J Cell Biol 2012; 2012:736905; PMID:22518139; http://dx.doi.org/10.1155/2012/736905
32. Yao TP. The role of ubiquitin in autophagy-dependent protein aggregate processing. Genes Cancer 2010; 1:779-86; PMID:21113398; http://dx.doi. org/10.1177/1947601910383277
33. Hofmann RM, Pickart CM. Noncanonical MMS2- encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 1999; 96:645-53; PMID:10089880; http://dx.doi.org/10.1016/S0092-8674(00)80575-9
34. Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z. Regulation of p53 localization and activity by Ubc13. Mol Cell Biol 2006; 26:8901- 13; PMID:17000756; http://dx.doi.org/10.1128/MCB.01156-06
35. Li D, Marchenko ND, Schulz R, Fischer V, Velasco-Hernandez T, Talos F, et al. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res 2011; 9:577-88; PMID:21478269; http://dx.doi.org/10.1158/1541- 7786.MCR-10-0534
36. Lukashchuk N, Vousden KH. Ubiquitination and degradation of mutant p53. Mol Cell Biol 2007; 27:8284-95; PMID:17908790; http://dx.doi. org/10.1128/MCB.00050-07
37. Zhang M, Windheim M, Roe SM, Peggie M, Cohen P, Prodromou C, et al. Chaperoned ubiquitylation- -crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Mol Cell 2005; 20:525-38; PMID:16307917; http://dx.doi. org/10.1016/j.molcel.2005.09.023
38. David Y, Ternette N, Edelmann MJ, Ziv T, Gayer B, Sertchook R, et al. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J Biol Chem 2011; 286:44104-15; PMID:21965653; http://dx.doi.org/10.1074/jbc. M111.234559
39. Sehat B, Andersson S, Girnita L, Larsson O. Identification of c-Cbl as a new ligase for insulinlike growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res 2008; 68:5669-77; PMID:18632619; http://dx.doi.org/10.1158/0008-5472.CAN-07- 6364
40. Wilcken R, Wang G, Boeckler FM, Fersht AR. Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition. Proc Natl Acad Sci USA 2012; 109:13584-9; PMID:22869713; http://dx.doi. org/10.1073/pnas.1211550109
41. Xu J, Reumers J, Couceiro JR, De Smet F, Gallardo R, Rudyak S, et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol 2011; 7:285-95; PMID:21445056; http://dx.doi.org/10.1038/ nchembio.546
42. Wong E, Bejarano E, Rakshit M, Lee K, Hanson HH, Zaarur N, et al. Molecular determinants of selective clearance of protein inclusions by autophagy. Nat Commun 2012; 3:1240; PMID:23212369; http://dx.doi.org/10.1038/ ncomms2244
43. Kirilyuk A, Shimoji M, Catania J, Sahu G, Pattabiraman N, Giordano A, et al. An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation. PLoS ONE 2012; 7:e48243; PMID:23133622; http://dx.doi.org/10.1371/journal. pone.0048243
44. Lee IH, Finkel T. Regulation of autophagy by the p300 acetyltransferase. J Biol Chem 2009; 284:6322- 8; PMID:19124466; http://dx.doi.org/10.1074/jbc. M807135200
45. Russell SE, Hickey GI, Lowry WS, White P, Atkinson RJ. Allele loss from chromosome 17 in ovarian cancer. Oncogene 1990; 5:1581-3; PMID:2250914
46. Futreal PA, Söderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 1992; 52:2624-7; PMID:1568230
47. Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008; 7:3056-61; PMID:18818522; http://dx.doi. org/10.4161/cc.7.19.6751
48. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-34; PMID:16839881; http://dx.doi. org/10.1016/j.cell.2006.05.034
49. White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 2010; 22:212- 7; PMID:20056400; http://dx.doi.org/10.1016/j. ceb.2009.12.008
50. Hanel W, Moll UM. Links between mutant p53 and genomic instability. J Cell Biochem 2012; 113:433- 9; PMID:22006292; http://dx.doi.org/10.1002/jcb. 23400